National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2019 (No. 6) (PB 46 of 2019) (Cth)

Case

PB 46 of 2019

National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2019 (No. 6)

National Health Act 1953

________________________________________________________________________

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Instrument under sections 84AF, 84AK, 85, 85A, 88 and 101 of the National Health Act 1953.

Dated    27 June 2019

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

  1. Name of Instrument

(1)This Instrument is the National Health (Listing of Pharmaceutical Benefits) Amendment Instrument 2019 (No. 6).

(2)This Instrument may also be cited as PB 46 of 2019.

  1. Commencement

This Instrument commences on 1 July 2019.

  1. Amendment of National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012)

Schedule 1 amends the National Health (Listing of Pharmaceutical Benefits) Instrument 2012 (PB 71 of 2012).

Schedule 1     Amendments

  1. Schedule 1, omit entry for Abciximab

  1. Schedule 1, entry for Amino acid formula with vitamins and minerals without phenylalanine

omit:

Oral powder 500 g (XP Maxamaid) Oral XP Maxamaid SB MP NP C4295 8 5 1

  1. Schedule 1, entry for Amoxicillin with clavulanic acid in the form Tablet containing 875 mg amoxicillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)

(a)omit:

a Chem mart Amoxycillin and Clavulanic Acid CH PDP C5833 C5894 10 0 10

(b)omit:

a Terry White Chemists Amoxycillin and Clavulanic Acid TW PDP C5833 C5894 10 0 10

(c)omit:

a Chem mart Amoxycillin and Clavulanic Acid CH MP NP C5832 C5893 10 1 10

(d)omit:

a Terry White Chemists Amoxycillin and Clavulanic Acid TW MP NP C5832 C5893 10 1 10

  1. Schedule 1, entry for Atorvastatin in the form Tablet 10 mg (as calcium)

(a)omit:

a Chem mart Atorvastatin CH MP NP 30 5 30

(b)omit:

a Chem mart Atorvastatin CH MP P7598 30 11 30

  1. Schedule 1, entry for Atorvastatin in the form Tablet 20 mg (as calcium)

(a)omit:

a Chem mart Atorvastatin CH MP NP 30 5 30

(b)omit:

a Chem mart Atorvastatin CH MP P7598 30 11 30

  1. Schedule 1, entry for Atorvastatin in the form Tablet 40 mg (as calcium)

(a)omit:

a Chem mart Atorvastatin CH MP NP 30 5 30

(b)omit:

a Chem mart Atorvastatin CH MP P7598 30 11 30

  1. Schedule 1, entry for Atorvastatin in the form Tablet 80 mg (as calcium)

(a)omit:

a Chem mart Atorvastatin CH MP NP 30 5 30

(b)omit:

a Chem mart Atorvastatin CH MP P7598 30 11 30

  1. Schedule 1, entry for Bosentan in each of the forms: Tablet 62.5 mg (as monohydrate); and Tablet 125 mg (as monohydrate)

omit:

a Bosentan APOTEX TX MP See Note 3 See Note 3 See Note 3 See Note 3 60 D(100)

  1. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 4 mg

omit:

a Chem mart Candesartan CH MP NP 30 5 30
a Terry White Chemists Candesartan TW MP NP 30 5 30

  1. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 8 mg

omit:

a Chem mart Candesartan CH MP NP 30 5 30
a Terry White Chemists Candesartan TW MP NP 30 5 30

  1. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 16 mg

omit:

a Chem mart Candesartan CH MP NP 30 5 30
a Terry White Chemists Candesartan TW MP NP 30 5 30

  1. Schedule 1, entry for Candesartan in the form Tablet containing candesartan cilexetil 32 mg

omit:

a Chem mart Candesartan CH MP NP 30 5 30
a Terry White Chemists Candesartan TW MP NP 30 5 30

  1. Schedule 1, entry for Candesartan with hydrochlorothiazide in the form Tablet containing candesartan cilexetil 16 mg with
    hydrochlorothiazide 12.5 mg

omit:

a Chem mart Candesartan HCTZ 16/12.5 CH MP NP C4374 30 5 30
a Terry White Chemists Candesartan HCTZ 16/12.5 TW MP NP C4374 30 5 30

  1. Schedule 1, entry for Candesartan with hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with
    hydrochlorothiazide 12.5 mg

omit:

a Chem mart Candesartan HCTZ 32/12.5 CH MP NP C4374 30 5 30
a Terry White Chemists Candesartan HCTZ 32/12.5 TW MP NP C4374 30 5 30

  1. Schedule 1, entry for Candesartan with hydrochlorothiazide in the form Tablet containing candesartan cilexetil 32 mg with
    hydrochlorothiazide 25 mg

omit:

a Chem mart Candesartan HCTZ 32/25 CH MP NP C4374 30 5 30
a Terry White Chemists Candesartan HCTZ 32/25 TW MP NP C4374 30 5 30

  1. Schedule 1, entry for Celecoxib in the form Capsule 100 mg

(a)insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Celecoxib BTC JB MP NP C4907 C4962 60 3 60

(b)insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a GenRx Celecoxib GX MP NP C4907 C4962 60 3 60

  1. Schedule 1, entry for Celecoxib in the form Capsule 200 mg

(a)insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Celecoxib BTC JB MP NP C4907 C4962 30 3 30

(b)insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a GenRx Celecoxib GX MP NP C4907 C4962 30 3 30

  1. Schedule 1, entry for Clarithromycin in the form Tablet 250 mg

(a)omit:

a Chem mart Clarithromycin CH MP NP 14 1 14

(b)omit:

a Terry White Chemists Clarithromycin TW MP NP 14 1 14

  1. Schedule 1, entry for Clopidogrel with aspirin

(a)omit:

a Chem mart Clopidogrel/Aspirin 75/100 CH MP NP C5443 C5488 C5517 30 5 30

(b)omit:

a Terry White Chemists Clopidogrel/Aspirin 75/100 TW MP NP C5443 C5488 C5517 30 5 30

  1. Schedule 1, omit entry for Cystine with carbohydrate

  1. Schedule 1, entry for Fenofibrate in the form Tablet 48 mg [Maximum Quantity: 60; Number of Repeats: 5]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Fenofibrate Mylan AF MP NP 60 5 60

  1. Schedule 1, entry for Fenofibrate in the form Tablet 48 mg [Maximum Quantity: 60; Number of Repeats: 11]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Fenofibrate Mylan AF MP P7640 60 11 60

  1. Schedule 1, entry for Fenofibrate in the form Tablet 145 mg [Maximum Quantity: 30; Number of Repeats: 5]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Fenofibrate Mylan AF MP NP 30 5 30

  1. Schedule 1, entry for Fenofibrate in the form Tablet 145 mg [Maximum Quantity: 30; Number of Repeats: 11]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”: 

a Fenofibrate Mylan AF MP P7640 30 11 30

  1. Schedule 1, entry for Fluorometholone

substitute:

Fluorometholone Eye drops 1 mg per mL, 5 mL Application to the eye FML Liquifilm AG AO 1 0 1
MP NP 1 5 1
Eye drops containing fluorometholone acetate 1 mg per mL, 5 mL Application to the eye Flarex NV AO 1 0 1
MP NP 1 2 1

  1. Schedule 1, entry for Glatiramer

omit:

Injection containing glatiramer acetate 20 mg in 1 mL single dose pre-filled syringe Injection Copaxone TB MP C6860 C7695 28 5 28

  1. Schedule 1, entry for Indapamide in the form Tablet containing indapamide hemihydrate 1.5 mg (sustained release)

(a)omit:

a Chem mart Indapamide SR CH MP NP 90 1 90

(b)omit:

a Terry White Chemists Indapamide SR TW MP NP 90 1 90

  1. Schedule 1, entry for Irbesartan in each of the forms: Tablet 75 mg; Tablet 150 mg; and Tablet 300 mg

omit:

a Abisart AF MP NP 30 5 30

  1. Schedule 1, entry for Irbesartan with hydrochlorothiazide in the form Tablet 150 mg-12.5 mg

omit:

a Abisart HCT 150/12.5 AF MP NP C4374 30 5 30

  1. Schedule 1, entry for Irbesartan with hydrochlorothiazide in the form Tablet 300 mg-12.5 mg

omit:

a Abisart HCT 300/12.5 AF MP NP C4374 30 5 30

  1. Schedule 1, entry for Irbesartan with hydrochlorothiazide in the form Tablet 300 mg-25 mg

omit:

a Abisart HCT 300/25 AF MP NP C4374 30 5 30

  1. Schedule 1, entry for Isosorbide mononitrate in the form Tablet 60 mg (sustained release)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a APO-Isosorbide Mononitrate TX MP NP 30 5 30

  1. Schedule 1, entry for Isotretinoin

insert as first entry:

Capsule 5 mg Oral Oratane OU MP C5224 60 3 60

  1. Schedule 1, entry for Lercanidipine in each of the forms: Tablet containing lercanidipine hydrochloride 10 mg; and Tablet containing lercanidipine hydrochloride 20 mg

(a)omit:

a Chem mart Lercanidipine CH MP NP 28 5 28

(b)omit:

a Terry White Chemists Lercanidipine TW MP NP 28 5 28

  1. Schedule 1, entry for Letrozole

(a)omit:

a Chem mart Letrozole CH MP NP C5464 30 5 30

(b)omit:

a Terry White Chemists Letrozole TW MP NP C5464 30 5 30

  1. Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg

omit:

a Formet Aspen 500 RW MP NP 100 5 100

  1. Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 850 mg

omit:

a Formet Aspen 850 RW MP NP 60 5 60

  1. Schedule 1, entry for Metoprolol succinate in the form Tablet 23.75 mg (controlled release)

omit:

a Toprol-XL 23.75 AP MP NP C5324 15 0 15

  1. Schedule 1, entry for Moclobemide in the form Tablet 150 mg

omit:

a GenRx Moclobemide GX MP NP C5650 60 5 60

  1. Schedule 1, entry for Montelukast in the form Tablet, chewable, 4 mg (as sodium)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Montelukast APOTEX GX MP NP C6666 28 5 28

  1. Schedule 1, entry for Montelukast in the form Tablet, chewable, 5 mg (as sodium)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Montelukast APOTEX GX MP NP C6674 C7781 28 5 28

  1. Schedule 1, entry for Olanzapine in each of the forms: Tablet 2.5 mg; and Tablet 5 mg

(a)omit:

a Chem mart Olanzapine CH MP NP C5856 C5869 28 5 28

(b)omit:

a Terry White Chemists Olanzapine TW MP NP C5856 C5869 28 5 28

  1. Schedule 1, entry for Olanzapine in the form Tablet 7.5 mg

(a)omit:

Chem mart Olanzapine CH MP NP C5856 C5869 28 5 28

(b)omit:

Terry White Chemists Olanzapine TW MP NP C5856 C5869 28 5 28

  1. Schedule 1, entry for Olanzapine in the form Tablet 10 mg

(a)omit:

a Chem mart Olanzapine CH MP NP C5856 C5869 28 5 28

(b)omit:

a Terry White Chemists Olanzapine TW MP NP C5856 C5869 28 5 28

  1. Schedule 1, entry for Olmesartan with amlodipine in the form Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Olmesartan/Amlodipine 20/5 APOTEX TX MP NP C4373 30 5 30

  1. Schedule 1, entry for Olmesartan with amlodipine in the form Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Olmesartan/Amlodipine 40/5 APOTEX TX MP NP C4373 30 5 30

  1. Schedule 1, entry for Olmesartan with amlodipine in the form Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg
    (as besilate)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Olmesartan/Amlodipine 40/10 APOTEX TX MP NP C4373 30 5 30

  1. Schedule 1, entry for Omeprazole in the form Tablet 20 mg

(a)omit:

Chem mart Omeprazole CH MP NP C8774 C8775 C8776 C8780 C8866 P8774 P8775 30 1 30

(b)omit:

Terry White Chemists Omeprazole TW MP NP C8774 C8775 C8776 C8780 C8866 P8774 P8775 30 1 30

(c)omit:

Chem mart Omeprazole CH MP NP C8774 C8775 C8776 C8780 C8866 P8776 P8780 P8866 30 5 30

(d)omit:

Terry White Chemists Omeprazole TW MP NP C8774 C8775 C8776 C8780 C8866 P8776 P8780 P8866 30 5 30

  1. Schedule 1, entry for Paracetamol in the form Tablet 500 mg [Maximum Quantity: 100; Number of Repeats: 0]

(a)omit:

a Generic Health Pty Ltd GQ PDP C5846 C5885 P5846 100 0 100

(b)insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Paracetamol Generic Health GQ PDP C5846 C5885 P5846 100 0 100

  1. Schedule 1, entry for Paracetamol in the form Tablet 500 mg [Maximum Quantity: 100; Number of Repeats: 1]

(a)omit:

a Generic Health Pty Ltd GQ MP NP C5835 C5865 P5835 100 1 100

(b)insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Paracetamol Generic Health GQ MP NP C5835 C5865 P5835 100 1 100

  1. Schedule 1, entry for Paracetamol in the form Tablet 500 mg [Maximum Quantity: 300; Number of Repeats: 0]

(a)omit:

a Generic Health Pty Ltd GQ PDP C5846 C5885 P5885 300 0 100

(b)insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Paracetamol Generic Health GQ PDP C5846 C5885 P5885 300 0 100

  1. Schedule 1, entry for Paracetamol in the form Tablet 500 mg [Maximum Quantity: 300; Number of Repeats: 4]

(a)omit:

a Generic Health Pty Ltd GQ MP NP C5835 C5865 P5865 300 4 100

(b)insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Paracetamol Generic Health GQ MP NP C5835 C5865 P5865 300 4 100

  1. Schedule 1, entry for Pemetrexed in each of the forms: Powder for I.V. infusion 100 mg (as disodium); Powder for I.V. infusion 500 mg (as disodium); and Powder for I.V. infusion 1 g (as disodium)

omit from the column headed “Circumstances” (all instances): C4792 C7195

  1. Schedule 1, after entry for Phenelzine in the form Tablet 15 mg (as sulfate)

insert:

Tablet 15 mg (as sulfate) (USP) Oral Nardil LM MP C6236 100 1 60

  1. Schedule 1, entry for Pioglitazone in each of the forms: Tablet 15 mg (as hydrochloride); Tablet 30 mg (as hydrochloride); and Tablet 45 mg
    (as hydrochloride)

(a)omit:

a Chem mart Pioglitazone CH MP NP C4363 C4364 C4388 28 5 28

(b)omit:

a Terry White Chemists Pioglitazone TW MP NP C4363 C4364 C4388 28 5 28

  1. Schedule 1, omit entry for Pyrimethamine

  1. Schedule 1, entry for Raloxifene

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Raloxifene GH GQ MP NP C6314 28 5 28

  1. Schedule 1, entry for Ramipril in each of the forms: Capsule 2.5 mg; and Capsule 5 mg

omit:

Chem mart Ramipril CH MP NP 30 5 30
Terry White Chemists Ramipril TW MP NP 30 5 30

  1. Schedule 1, entry for Ramipril in the form Capsule 10 mg

(a)omit:

Chem mart Ramipril CH MP NP 30 5 30

(b)omit:

Terry White Chemists Ramipril TW MP NP 30 5 30

  1. Schedule 1, entry for Ramipril in each of the forms: Tablet 2.5 mg; and Tablet 5 mg

(a)omit:

Chem mart Ramipril CH MP NP 30 5 30

(b)omit:

Terry White Chemists Ramipril TW MP NP 30 5 30

  1. Schedule 1, entry for Ritonavir

omit:

Oral solution 600 mg per 7.5 mL (80 mg per mL), 90 mL Oral Norvir VE MP C4454 C4512 10 5 1 D(100)

  1. Schedule 1, omit entry for Rosiglitazone with metformin

  1. Schedule 1, entry for Sumatriptan in the form Tablet 50 mg (as succinate)

(a)omit:

Chem mart Sumatriptan CH MP NP C5259 4 5 2
MP NP C5259 4 5 4

(b)omit:

Terry White Chemists Sumatriptan TW MP NP C5259 4 5 2
MP NP C5259 4 5 4

  1. Schedule 1, entry for Temozolomide in the form Capsule 5 mg [Maximum Quantity: 5; Number of Repeats: 5]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Temozolomide Juno JX MP 5 5 5

  1. Schedule 1, entry for Temozolomide in the form Capsule 5 mg [Maximum Quantity: 15; Number of Repeats: 2]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Temozolomide Juno JX MP P4897 15 2 5

  1. Schedule 1, entry for Temozolomide in the form Capsule 20 mg [Maximum Quantity: 5; Number of Repeats: 5]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Temozolomide Juno JX MP 5 5 5

  1. Schedule 1, entry for Temozolomide in the form Capsule 20 mg [Maximum Quantity: 15; Number of Repeats: 2]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Temozolomide Juno JX MP P4897 15 2 5

  1. Schedule 1, entry for Temozolomide in the form Capsule 100 mg [Maximum Quantity: 5; Number of Repeats: 5]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Temozolomide Juno JX MP 5 5 5

  1. Schedule 1, entry for Temozolomide in the form Capsule 100 mg [Maximum Quantity: 15; Number of Repeats: 2]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Temozolomide Juno JX MP P4897 15 2 5

  1. Schedule 1, entry for Temozolomide in the form Capsule 140 mg [Maximum Quantity: 5; Number of Repeats: 5]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Temozolomide Juno JX MP 5 5 5

  1. Schedule 1, entry for Temozolomide in the form Capsule 140 mg [Maximum Quantity: 15; Number of Repeats: 2]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Temozolomide Juno JX MP P4897 15 2 5

  1. Schedule 1, entry for Temozolomide in the form Capsule 180 mg [Maximum Quantity: 5; Number of Repeats: 5]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Temozolomide Juno JX MP 5 5 5

  1. Schedule 1, entry for Temozolomide in the form Capsule 180 mg [Maximum Quantity: 15; Number of Repeats: 2]

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Temozolomide Juno JX MP P4897 15 2 5

  1. Schedule 1, entry for Temozolomide in the form Capsule 250 mg

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Temozolomide Juno JX MP 5 5 5

  1. Schedule 1, entry for Tirofiban

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Tirofiban Juno JU MP NP C5691 C5782 C5809 1 2 1

  1. Schedule 1, entry for Valaciclovir in the form Tablet 500 mg (as hydrochloride)

(a)omit:

a Chem mart Valaciclovir CH MP NP C5940 C5961 C5962 C5968 P5940 P5961 30 5 30

(b)omit:

a Terry White Chemists Valaciclovir TW MP NP C5940 C5961 C5962 C5968 P5940 P5961 30 5 30

(c)omit:

a Chem mart Valaciclovir CH MP NP C5940 C5961 C5962 C5968 P5962 P5968 42 0 42
a Terry White Chemists Valaciclovir TW MP NP C5940 C5961 C5962 C5968 P5962 P5968 42 0 42

  1. Schedule 1, entry for Ziprasidone in each of the forms: Capsule 20 mg (as hydrochloride); Capsule 40 mg (as hydrochloride); Capsule 60 mg (as hydrochloride); and Capsule 80 mg (as hydrochloride)

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

a Ziprasidone GH GQ MP NP C4246 C5742 60 5 60

  1. Schedule 1, entry for Zoledronic acid in the form Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL

insert in the columns in the order indicated, and in alphabetical order for the column headed “Brand”:

DEZTRON DZ MP C5605 C5606 C5676 C5677 C5703 C5704 C5735 C5736 1 11 1 PB(100)

  1. Schedule 3, after details relevant to Responsible Person code OS

insert:

OU Oraderm Pharmaceuticals Pty Ltd 50 612 828 618

  1. Schedule 4, Part 1, omit entry for Abciximab

  1. Schedule 4, Part 1, omit entry for Cystine with carbohydrate

  1. Schedule 4, Part 1, omit entry for Pemetrexed

  1. Schedule 4, Part 1, omit entry for Rosiglitazone with metformin

  1. Schedule 5, entry for Olanzapine in the form Tablet 7.5 mg [GRP-15884]

(a)omit from the column headed “Brand”: Chem mart Olanzapine

(b)omit from the column headed “Brand”: Terry White Chemists Olanzapine

  1. Schedule 5, entry for Omeprazole in the form Tablet 20 mg [GRP-14650]

(a)omit from the column headed “Brand”: Chem mart Omeprazole

(b)omit from the column headed “Brand”: Terry White Chemists Omeprazole

  1. Schedule 5, after entry for Perindopril with indapamide [GRP-15765]

insert:

Phenelzine GRP-23097 Tablet 15 mg (as sulfate) Oral Nardil
Tablet 15 mg (as sulfate) (USP) Oral Nardil

  1. Schedule 5, entry for Ramipril in each of the forms: Capsule 5 mg; and Tablet 5 mg [GRP-15424]

(a)omit from the column headed “Brand”: Chem mart Ramipril

(b)omit from the column headed “Brand”: Terry White Chemists Ramipril

  1. Schedule 5, entry for Ramipril in the form Capsule 10 mg [GRP-15431]

(a)omit from the column headed “Brand”: Chem mart Ramipril

(b)omit from the column headed “Brand”: Terry White Chemists Ramipril

  1. Schedule 5, entry for Ramipril in each of the forms: Capsule 2.5 mg; and Tablet 2.5 mg [GRP-15769]

(a)omit from the column headed “Brand”: Chem mart Ramipril

(b)omit from the column headed “Brand”: Terry White Chemists Ramipril

  1. Schedule 5, entry for Sumatriptan

substitute:

Sumatriptan GRP-15928 Tablet (fast disintegrating) 50 mg (as succinate) Oral Imigran FDT
Tablet 50 mg (as succinate) Oral APO-Sumatriptan
Imigran
Iptam
Pharmacor Sumatriptan 50
Sumatran
Sumatriptan AN
Sumatriptan Sandoz
Sumatriptan generichealth

  1. Schedule 5, entry for Zoledronic acid in the form Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL [GRP-17614]

insert in alphabetical order in the column headed “Brand”: DEZTRON

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0